John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 167 shares at $126.84 ($21K) on 2017-02-09, disclosed to the SEC on 2017-02-10.
Seasonal sale ($21k) by EVP & General Counsel — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |